These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37390601)

  • 1. Empirical evidence for the neurocognitive effect of nitrous oxide as an adjunctive therapy in patients with treatment resistant depression: A randomized controlled study.
    Liu J; Zhao X; Wei X; Yan D; Ou W; Liao M; Ji S; Peng Y; Wu S; Wang M; Ju Y; Zhang L; Li Z; Liu B; Li L; Zhang Y
    Psychiatry Res; 2023 Aug; 326():115326. PubMed ID: 37390601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of nitrous oxide for patients with treatment-resistant depression, a randomized controlled trial.
    Yan D; Liu B; Wei X; Ou W; Liao M; Ji S; Peng Y; Liu J; Wu S; Wang M; Ju Y; Zhang L; Li Z; Li L; Zhang Y
    Psychiatry Res; 2022 Nov; 317():114867. PubMed ID: 36191556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrous Oxide for Treatment-Resistant Major Depression: A Proof-of-Concept Trial.
    Nagele P; Duma A; Kopec M; Gebara MA; Parsoei A; Walker M; Janski A; Panagopoulos VN; Cristancho P; Miller JP; Zorumski CF; Conway CR
    Biol Psychiatry; 2015 Jul; 78(1):10-18. PubMed ID: 25577164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitrous oxide as an adjunctive therapy in major depressive disorder: a randomized controlled double-blind pilot trial.
    Guimarães MC; Guimarães TM; Hallak JE; Abrão J; Machado-de-Sousa JP
    Braz J Psychiatry; 2021; 43(5):484-493. PubMed ID: 33605397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain function changes reveal rapid antidepressant effects of nitrous oxide for treatment-resistant depression:Evidence from task-state EEG.
    Shao X; Yan D; Kong W; Sun S; Liao M; Ou W; Zhang Y; Zheng F; Li X; Li L; Hu B
    Psychiatry Res; 2023 Apr; 322():115072. PubMed ID: 36791487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrous oxide (N
    Stewart RM; Wong JWY; Runions KC; Rao P; Moore JK; Davies SR; von Ungern-Sternberg BS; Sommerfield D; Zepf FD
    Trials; 2017 Dec; 18(1):617. PubMed ID: 29273063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrous oxide analgesia for bone marrow aspiration and biopsy - A randomized, controlled and patient blinded study.
    Kuivalainen AM; Ebeling F; Poikonen E; Rosenberg PH
    Scand J Pain; 2015 Apr; 7(1):28-34. PubMed ID: 29911602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of nitrous oxide in the treatment of major depressive disorder and treatment-resistant major depressive disorder: A systematic review and meta-analysis nitrous oxide in depressive disorders.
    Rech P; Custodio RM; Rodrigues Uggioni ML; Silveira Prestes G; Marçal F; Silveira VP; Dagostin VS; Colonetti T; Rosa MI
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Feb; 129():110869. PubMed ID: 37813146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial.
    Murrough JW; Burdick KE; Levitch CF; Perez AM; Brallier JW; Chang LC; Foulkes A; Charney DS; Mathew SJ; Iosifescu DV
    Neuropsychopharmacology; 2015 Mar; 40(5):1084-90. PubMed ID: 25374095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression.
    Nagele P; Palanca BJ; Gott B; Brown F; Barnes L; Nguyen T; Xiong W; Salloum NC; Espejo GD; Lessov-Schlaggar CN; Jain N; Cheng WWL; Komen H; Yee B; Bolzenius JD; Janski A; Gibbons R; Zorumski CF; Conway CR
    Sci Transl Med; 2021 Jun; 13(597):. PubMed ID: 34108247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equimolar mixture of nitroux oxyde and oxygen during post-operative physiotherapy in patients with cerebral palsy: A randomized, double-blind, placebo-controlled study.
    Delafontaine A; Presedo A; Mohamed D; Lopes D; Wood C; Alberti C
    Eur J Pain; 2017 Nov; 21(10):1657-1667. PubMed ID: 28726270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive performance of repeated versus single intravenous subanesthetic ketamine in treatment resistant depression.
    Shiroma PR; Thuras P; Wels J; Albott CS; Erbes C; Tye S; Lim KO
    J Affect Disord; 2020 Dec; 277():470-477. PubMed ID: 32871534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Minocycline on Depressive Symptoms in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.
    Hellmann-Regen J; Clemens V; Grözinger M; Kornhuber J; Reif A; Prvulovic D; Goya-Maldonado R; Wiltfang J; Gruber O; Schüle C; Padberg F; Ising M; Uhr M; Friede T; Huber C; Manook A; Baghai TC; Rupprecht R; Heuser I
    JAMA Netw Open; 2022 Sep; 5(9):e2230367. PubMed ID: 36103181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive effects of subanesthetic serial ketamine infusions in treatment resistant depression.
    Zavaliangos-Petropulu A; McClintock SM; Khalil J; Joshi SH; Taraku B; Al-Sharif NB; Espinoza RT; Narr KL
    J Affect Disord; 2023 Jul; 333():161-171. PubMed ID: 37060953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multicenter, triple-blind randomized placebo controlled trial of adjuvant nitrous oxide 50% in oxygen 50%: efficacy for reducing pain and increasing satisfaction in patients treated for renal colic in the emergency department].
    Aguilar Mulet JM; Álvarez Rodríguez V; Borobia Pérez AM; Velayos Rubio R; Ochoa Mazarro MD; Del Arco Galán C
    Emergencias; 2016 Oct; 28(5):305-312. PubMed ID: 29106100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proof-of-concept randomized controlled trial of single-session nitrous oxide treatment for refractory bipolar depression: Focus on cerebrovascular target engagement.
    Kim WSH; Dimick MK; Omrin D; Mitchell RHB; Riegert D; Levitt A; Schaffer A; Belo S; Iazzetta J; Detzler G; Choi M; Choi S; Herrmann N; McIntyre RS; MacIntosh BJ; Orser BA; Goldstein BI
    Bipolar Disord; 2023 May; 25(3):221-232. PubMed ID: 36579458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of and physiological responses to nitrous oxide gas treatment during alcohol withdrawal: a double-blind, placebo-controlled trial.
    Alho H; Methuen T; Paloheimo M; Strid N; Seppä K; Tiainen J; Salaspuro M; Roine R
    Alcohol Clin Exp Res; 2002 Dec; 26(12):1816-22. PubMed ID: 12500105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Design Trial of Adjunctive Riluzole for Treatment-Resistant Major Depressive Disorder.
    Mathew SJ; Gueorguieva R; Brandt C; Fava M; Sanacora G
    Neuropsychopharmacology; 2017 Dec; 42(13):2567-2574. PubMed ID: 28553836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Fixed Nitrous Oxide and Oxygen Mixture for Analgesia in Children With Leukemia With Lumbar Puncture-induced Pain: A Randomized, Double-blind Controlled Trial.
    Liu Q; Chai XM; Zhang JJ; Wang YL; Wang Y; Gao LL; Dai YL; Gao HX; Zhang TT; Yu JQ; Li YX
    J Pain Symptom Manage; 2019 Jun; 57(6):1043-1050. PubMed ID: 30853549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial.
    Yang C; Bosker FJ; Li J; Schoevers RA
    BMC Psychiatry; 2018 Sep; 18(1):279. PubMed ID: 30176835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.